AROLDI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.409
EU - Europa 1.017
AS - Asia 439
SA - Sud America 35
AF - Africa 9
OC - Oceania 1
Totale 2.910
Nazione #
US - Stati Uniti d'America 1.397
IT - Italia 440
SG - Singapore 186
DE - Germania 169
IE - Irlanda 133
CN - Cina 96
SE - Svezia 89
RU - Federazione Russa 65
HK - Hong Kong 59
ID - Indonesia 29
BR - Brasile 24
GB - Regno Unito 24
FI - Finlandia 22
IN - India 16
TR - Turchia 13
VN - Vietnam 13
NL - Olanda 12
FR - Francia 10
CA - Canada 9
PT - Portogallo 8
CZ - Repubblica Ceca 7
UA - Ucraina 7
EG - Egitto 6
ES - Italia 6
IR - Iran 6
AR - Argentina 5
AT - Austria 5
CO - Colombia 5
NO - Norvegia 5
PL - Polonia 5
BG - Bulgaria 3
IL - Israele 3
KG - Kirghizistan 3
AM - Armenia 2
AZ - Azerbaigian 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MA - Marocco 2
PH - Filippine 2
RS - Serbia 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
MX - Messico 1
PA - Panama 1
PK - Pakistan 1
TW - Taiwan 1
Totale 2.910
Città #
Ann Arbor 545
Milan 138
Singapore 136
Dublin 133
Frankfurt am Main 119
Chandler 86
New York 74
Fairfield 70
Wilmington 68
Woodbridge 62
Hong Kong 53
Santa Clara 52
Ashburn 39
Seattle 34
Houston 32
Shanghai 29
Jakarta 28
Princeton 24
Cambridge 20
Lissone 19
Monza 17
Helsinki 14
Los Angeles 14
Romola 14
Rome 13
Lawrence 12
Altamura 11
Munich 11
Nuremberg 10
Beijing 9
Dallas 9
Guangzhou 9
Bologna 8
Como 8
Dong Ket 8
Jacksonville 8
San Diego 8
Turin 8
Dearborn 7
Sesto San Giovanni 7
Boardman 6
Carate Brianza 6
Council Bluffs 6
Fremont 6
Lappeenranta 6
London 6
Seregno 6
Andover 5
Tianjin 5
Assago 4
Bonndorf 4
Cinisello Balsamo 4
Desio 4
Falls Church 4
Genoa 4
Lisbon 4
Lodz 4
Olomouc 4
Oslo 4
Pune 4
Sacramento 4
Tehran 4
Toronto 4
Agrate Brianza 3
Ankara 3
Arese 3
Bari 3
Bergamo 3
Berlin 3
Bishkek 3
Bogotá 3
Ceret 3
Chicago 3
Colorado Springs 3
Corbetta 3
Delhi 3
Kocaeli 3
Legnano 3
Lleida 3
Nanchang 3
Sacavém 3
Seriate 3
Tel Aviv 3
Usmate Velate 3
Aurora 2
Baku 2
Bhopal 2
Cesano Maderno 2
Cologne 2
Coventry 2
Dresden 2
Garbsen 2
Gorgonzola 2
Haikou 2
Hangzhou 2
Hounslow 2
Huizhou 2
Jiaxing 2
Jinan 2
Kragujevac 2
Totale 2.169
Nome #
Chronic myeloid leukemia: Second-line drugs of choice 273
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 198
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 198
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 196
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study) 173
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making 171
Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019 171
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea 166
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 157
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 151
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies 136
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 120
Idiopathic erythrocytosis: a germline disease? 118
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success 112
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 97
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 94
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 86
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 72
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 70
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 70
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 63
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia 36
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 34
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 22
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 11
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 7
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options 7
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors 5
Totale 3.014
Categoria #
all - tutte 12.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 0 0 0 11 13 5 5
2020/2021663 37 17 66 57 58 75 58 60 69 47 58 61
2021/2022295 52 36 48 38 14 23 4 8 7 10 17 38
2022/2023421 37 117 37 27 24 62 29 8 35 12 26 7
2023/2024650 14 20 30 27 61 175 96 25 67 42 26 67
2024/2025805 56 141 88 76 119 88 113 69 55 0 0 0
Totale 3.014